Your session is about to expire
← Back to Search
Hormone Therapy
Continuous OC for Binge Eating Disorder
Phase 2
Waitlist Available
Led By Jessica Baker, PhD
Research Sponsored by University of North Carolina, Chapel Hill
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pre-intervention (week 1) to intervention endpoint (week 12)
Awards & highlights
Study Summary
This trial looks at how birth control affects the eating habits and brain activity of women with binge eating disorder.
Eligible Conditions
- Binge Eating Disorder
- Binge Eating
- Bulimia
- Eating Disorders
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ pre-intervention (week 1) to intervention endpoint (week 12)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~pre-intervention (week 1) to intervention endpoint (week 12)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change From Pre-intervention to Intervention Endpoint in Binge Eating Sum Score
Change From Pre-intervention to Intervention Endpoint in Delay Discounting Parameter k
Change From Pre-intervention to Intervention Endpoint in Dorsal Striatum Signal Intensity in Response to Reward During the Monetary Incentive Delay Task (MIDT)
+3 moreSecondary outcome measures
Change From Pre-intervention to Intervention Endpoint in Behavioral Inhibition Subscale Score
Change From Pre-intervention to Intervention Endpoint in Self-reported Reward Sensitivity Subscale Score
Trial Design
1Treatment groups
Experimental Treatment
Group I: Continuous OCExperimental Treatment1 Intervention
Continuous daily oral drospirenone + ethinyl estradiol for 84 days (i.e., 12-weeks).
Find a Location
Who is running the clinical trial?
University of North Carolina, Chapel HillLead Sponsor
1,508 Previous Clinical Trials
4,191,034 Total Patients Enrolled
Foundation of Hope, North CarolinaOTHER
15 Previous Clinical Trials
544 Total Patients Enrolled
Jessica Baker, PhDPrincipal InvestigatorUniversity of North Carolina, Chapel Hill
1 Previous Clinical Trials
10 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger